Skip to content

What is the drug Durela used for? Understanding Tramadol for Chronic Pain

4 min read

Durela is a brand name for extended-release tramadol, an opioid analgesic prescribed for the management of moderate to moderately severe pain in adults. Unlike immediate-release tramadol, Durela is specifically formulated to provide continuous, 24-hour pain control for patients requiring ongoing treatment.

Quick Summary

Durela is an opioid analgesic containing extended-release tramadol used for managing chronic, moderate to severe pain in adults. It works through a dual mechanism involving opioid and monoaminergic pathways to reduce pain signals. Proper administration is crucial due to potential risks, and it is not intended for acute pain.

Key Points

  • Extended-Release Formulation: Durela is an extended-release version of the opioid pain reliever tramadol, designed for once-daily dosing to manage chronic pain.

  • Dual Mechanism of Action: It provides pain relief by activating opioid receptors and inhibiting the reuptake of serotonin and norepinephrine, targeting multiple pain pathways.

  • Used for Chronic Pain: Durela is indicated for the management of moderate to moderately severe pain that requires continuous, around-the-clock treatment in adults.

  • High-Risk Medication: Like other opioids, Durela carries risks of addiction, abuse, misuse, and life-threatening respiratory depression, requiring careful medical supervision.

  • Crucial Administration Details: Capsules must be swallowed whole to avoid the rapid release of tramadol, which can lead to a fatal overdose.

  • Distinct from Dulera: Durela (tramadol for pain) should not be confused with Dulera (mometasone/formoterol for asthma), as they treat different conditions and have different active ingredients.

In This Article

What is Durela?

Durela is the brand name for an extended-release form of the prescription medication tramadol hydrochloride. It belongs to a class of drugs known as opioid analgesics and is used to treat moderate to moderately severe chronic pain. This formulation is distinct from immediate-release tramadol because it is designed to be taken once daily, delivering the medication over a prolonged period to ensure continuous pain relief. This makes it suitable for patients who require round-the-clock pain management for several days or more, and for whom alternative, non-opioid treatments have been inadequate.

The Mechanism of Action

Tramadol, the active ingredient in Durela, functions differently than traditional opioid agonists like morphine. Instead of relying on a single pathway, it uses a dual mechanism to reduce pain:

  • Opioid Receptor Agonism: Tramadol and its metabolite, O-desmethyltramadol (M1), activate the mu-opioid receptors in the central nervous system. This action blocks the transmission of pain signals to the brain, providing an analgesic effect. The M1 metabolite is actually a more potent opioid than the parent drug and contributes significantly to the overall pain relief.
  • Monoaminergic Pathway Modulation: Tramadol also weakly inhibits the reuptake of norepinephrine and serotonin. By increasing the levels of these neurotransmitters in the spinal cord, it enhances the body's own descending pain-inhibitory pathways.

This dual-action approach is what makes tramadol an effective and unique pain-relief medication.

Prescribing and Usage of Durela

Dosage and Administration

Durela is taken orally as an extended-release capsule, typically once every 24 hours. It is critical that patients swallow the capsule whole and do not crush, chew, or dissolve it. Altering the capsule's form can lead to the rapid absorption of a potentially fatal dose of tramadol. If a dose is missed, patients should skip the missed dose and resume their regular schedule rather than taking a double dose.

Important Safety Precautions

Because Durela is an opioid, its use comes with significant risks that require careful management by a healthcare professional. Key precautions include:

  • Risk of Addiction, Abuse, and Misuse: As with all opioids, Durela has a high potential for addiction, abuse, and misuse, which can lead to overdose and death. Patients must be regularly monitored for these behaviors.
  • Respiratory Depression: Serious, life-threatening, or fatal respiratory depression can occur, especially when starting the medication or increasing the dose.
  • Interactions with CNS Depressants: Co-ingestion with alcohol, benzodiazepines, or other central nervous system (CNS) depressants can result in profound sedation, respiratory depression, coma, and death.
  • Seizure Risk: Tramadol can cause seizures, and the risk is higher at higher doses or when taken with other medications that lower the seizure threshold.
  • Serotonin Syndrome: The risk of developing a potentially life-threatening serotonin syndrome is elevated when Durela is used with other serotonergic drugs, such as SSRIs, SNRIs, and MAOIs.
  • Withdrawal Symptoms: Suddenly stopping Durela can cause withdrawal symptoms, so it is important to taper off the medication under a doctor's supervision.

Understanding the Difference: Durela vs. Dulera

It is vital to distinguish between Durela (tramadol) and Dulera (mometasone/formoterol), as they are two completely different medications used for different purposes.

Feature Durela (Tramadol HCl) Dulera (Mometasone/Formoterol)
Active Ingredients Tramadol hydrochloride Mometasone furoate and Formoterol fumarate
Primary Use Management of moderate to moderately severe chronic pain Maintenance treatment for asthma symptoms
Drug Class Opioid analgesic Inhaled corticosteroid (ICS) and long-acting beta2-agonist (LABA) combination
Administration Oral extended-release capsule Oral inhalation via a metered-dose inhaler
Not Used For Acute pain or as-needed use Relief of acute, sudden breathing problems

Side Effects of Durela

Common side effects associated with Durela include:

  • Nausea and vomiting
  • Dizziness and drowsiness
  • Headache
  • Constipation
  • Dry mouth
  • Sweating
  • Itching
  • Confusion

More serious side effects are also possible and require immediate medical attention:

  • Seizures
  • Slow, shallow, or weak breathing
  • Signs of serotonin syndrome (e.g., agitation, confusion, fever, shivering)
  • Signs of a severe allergic reaction (hives, difficulty breathing, swelling)
  • Signs of adrenal gland disorders (fatigue, nausea, loss of appetite)

Drug Interactions

Durela can interact with many other medications, increasing the risk of adverse effects. Some important interactions to be aware of include:

  • CNS Depressants: Combining Durela with benzodiazepines, other opioids, alcohol, or sedatives can increase the risk of respiratory depression and profound sedation.
  • Serotonergic Drugs: Concomitant use with SSRIs, SNRIs, TCAs, MAOIs, or triptans increases the risk of serotonin syndrome.
  • MAO Inhibitors: Durela should not be used in patients taking MAOIs or within 14 days of stopping such treatment due to the potential for serious complications.
  • CYP3A4 and CYP2D6 Inhibitors: Medications that inhibit these liver enzymes can alter tramadol metabolism, potentially increasing the risk of side effects.

Patients should always inform their doctor about all prescription and over-the-counter medications, as well as any supplements, they are taking before starting Durela.

Conclusion

Durela, an extended-release tramadol, is a powerful and effective analgesic for managing moderate to moderately severe chronic pain in adults. Its dual mechanism of action, involving both opioid receptor agonism and modulation of monoaminergic pathways, provides sustained pain relief. However, as with all opioids, it is not without risk. Patients and healthcare providers must be vigilant about the potential for addiction, misuse, and serious side effects such as respiratory depression and serotonin syndrome. The extended-release formulation requires specific administration instructions, such as swallowing the capsule whole, to prevent fatal overdose. Proper usage under a doctor's supervision is essential for maximizing benefit while minimizing risk.


MedBroadcast.com: Durela - Uses, Side Effects, Interactions

Drugs.com: Dulera Inhaler: Side Effects, Dosage & Uses

Cipher Pharmaceuticals: DURELA® (tramadol hydrochloride)

ClinicalTrials.gov: Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal

Frequently Asked Questions

Durela is a brand name for the medication tramadol hydrochloride, but specifically for its extended-release formulation. It is different from immediate-release tramadol due to its once-daily dosing schedule for continuous pain management.

No, Durela is not intended for the relief of acute pain or as-needed use. Its extended-release formulation is specifically designed for the continuous management of chronic, moderate to severe pain.

Crushing, chewing, or dissolving Durela extended-release capsules can cause the rapid release and absorption of a large amount of tramadol at once, which could lead to a fatal overdose.

Common side effects include nausea, vomiting, dizziness, drowsiness, constipation, headache, and sweating.

Yes, serious risks include addiction, abuse, misuse, fatal respiratory depression, and serotonin syndrome, especially when taken with other serotonergic medications.

Yes, it is contraindicated in patients with significant respiratory depression, acute or severe bronchial asthma, GI obstruction, or hypersensitivity to tramadol. Caution is also advised for those with a history of substance abuse, seizures, or liver disease.

Durela is an oral opioid analgesic (tramadol) used for chronic pain. Dulera is an inhaled medication (mometasone/formoterol) used for maintenance treatment of asthma. They are completely different drugs.

No. The co-ingestion of alcohol with Durela can significantly increase the risk of serious side effects, including fatal respiratory depression.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.